Cargando…
Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents
BACKGROUND: The last decade has seen development of numerous novel antipsychotic drugs with unique mechanisms including long-acting formulations for clinical use. A comparative assessment of these new drugs with each other and previous antipsychotics have not been performed with regards to risk for...
Autores principales: | Kannarkat, George T., Caroff, Stanley N., Morley, James F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ubiquity Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187243/ https://www.ncbi.nlm.nih.gov/pubmed/35836971 http://dx.doi.org/10.5334/tohm.695 |
Ejemplares similares
-
Newer antipsychotics and the rabbit syndrome
por: Catena Dell'Osso, Mario, et al.
Publicado: (2007) -
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice
por: Hauser, Robert A., et al.
Publicado: (2022) -
Cardiotoxicity of current antipsychotics: Newer antipsychotics or adjunct therapy?
por: Liu, Zheng, et al.
Publicado: (2022) -
Experimental treatment of antipsychotic-induced movement disorders
por: Shireen, Erum
Publicado: (2016) -
Newer agents for Helicobacter pylori eradication
por: Fiorini, Giulia, et al.
Publicado: (2012)